Quick Answer
TANDEM DIABETES CARE INC reported Cash And Cash Equivalents At Carrying Value of $90.63 million for the year ending 2025.
- TANDEM DIABETES CARE INC showed an increase of +30.9% in Cash And Cash Equivalents At Carrying Value from 2024 to 2025.
- This data is from TANDEM DIABETES CARE INC's annual report (Form 10-K), filed with the SEC on February 19, 2026.
- XBRL data for this metric is available from 2011 to 2025 (15 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 15 years of available data (2011 to 2025), TANDEM DIABETES CARE INC's Cash And Cash Equivalents At Carrying Value has grown by 946.9%.
- Historical annual values: Fiscal year 2025: $90.63 million | Fiscal year 2024: $69.23 million | Fiscal year 2023: $58.87 million | Fiscal year 2022: $172.52 million | Fiscal year 2021: $71.18 million | Fiscal year 2020: $94.61 million | Fiscal year 2019: $51.18 million | Fiscal year 2018: $41.83 million | Fiscal year 2017: $13.70 million | Fiscal year 2016: $44.68 million | Fiscal year 2015: $43.09 million | Fiscal year 2014: $31.18 million | Fiscal year 2013: $124.39 million | Fiscal year 2012: $17.16 million | Fiscal year 2011: $8.66 million.
- Data sourced from SEC EDGAR public filings as of June 23, 2026.
Last verified: